Belsomra® (Suvorexant) 15 mg / 20 mg

Belsomra® (Suvorexant) 15 mg / 20 mg 100 tablets

Belsomra® is a prescription medication indicated for the treatment of insomnia in adults. It contains suvorexant, a selective orexin receptor antagonist that promotes natural sleep onset and maintenance.

Unlike traditional hypnotics, Belsomra® does not directly suppress the central nervous system but reduces wakefulness by inhibiting the orexin system.

Active Ingredient

• Suvorexant

Dosage Forms

• 100 Tablets 15 mg
• 100 Tablets 20 mg

Indications

• Insomnia in adults
• Difficulty falling asleep
• Frequent nighttime awakenings
• Reduced total sleep time

Administration and Dosage

Belsomra® is taken once nightly immediately before bedtime, when at least 7 hours remain before planned awakening.
The usual starting dose is 10–15 mg, with a maximum recommended dose of 20 mg as prescribed by a healthcare professional.

Mechanism of Action

Suvorexant blocks orexin receptors OX1R and OX2R, reducing wake drive and allowing normal sleep initiation and maintenance.

Benefits

• Non-benzodiazepine sleep aid
• Preserves normal sleep architecture
• Lower risk of dependence
• Suitable for long-term use under medical supervision

Possible Side Effects

• Next-day drowsiness
• Headache
• Dizziness
• Abnormal dreams
• Rarely: sleep paralysis or hallucinations

Contraindications

• Narcolepsy
• Hypersensitivity to suvorexant
• Severe hepatic impairment
• Concomitant use with strong CYP3A inhibitors

Manufacturer

MSD (Merck Sharp & Dohme)
Distributed by Daiichi Sankyo
Country of origin: Japan / USA

Ask a question or inquire about delivery to your country

Telegram

WhatsApp